1981
DOI: 10.1016/s0007-0971(81)80002-2
|View full text |Cite
|
Sign up to set email alerts
|

Prospects for an oral intal

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
15
0

Year Published

1983
1983
2000
2000

Publication Types

Select...
6
2
2

Relationship

1
9

Authors

Journals

citations
Cited by 66 publications
(16 citation statements)
references
References 54 publications
1
15
0
Order By: Relevance
“…This study has demonstrated that expression of an acute allergic reaction was insufficient to account for air way hyperreactivity in the guinea pig, which is consistent with the clinical finding that suppression of acute manifestations of the allergic response is not necessarily accompanied by diminished hyperreactivity (18,19) and the lack of clinical efficacy of compounds selected as anti asthma drugs by reference to acute allergic reactions (20). Observation of changed responsivity to inhaled spasmo gens following inhalation of allergen is a widely used tech nique for studying the airway hyperreactivity in clinical asthma.…”
Section: Discussionsupporting
confidence: 85%
“…This study has demonstrated that expression of an acute allergic reaction was insufficient to account for air way hyperreactivity in the guinea pig, which is consistent with the clinical finding that suppression of acute manifestations of the allergic response is not necessarily accompanied by diminished hyperreactivity (18,19) and the lack of clinical efficacy of compounds selected as anti asthma drugs by reference to acute allergic reactions (20). Observation of changed responsivity to inhaled spasmo gens following inhalation of allergen is a widely used tech nique for studying the airway hyperreactivity in clinical asthma.…”
Section: Discussionsupporting
confidence: 85%
“…SCG was originally introduced as a mast cell-stabilizing drug and the first of a novel class of therapeutic agents for the treatment of allergic diseases [8]. However, its mast cell-stabilizing property is unlikely to explain the therapeutic efficacy of SCG in the treatment of asthma, because many compounds that are far more potent in stabilizing mast cells have failed to show therapeutic usefulness [30]. More recently, SCG has been shown to inhibit bronchoconstrictor responses evoked by irritants including bradykinin [31] and sulphur dioxide [32].…”
Section: Discussionmentioning
confidence: 99%
“…Taylor & Sheldon (1977) have suggested that there may be an essential co-factor in lung tissue that enables SCG to affect mast cell stabilisation. It has also been argued (Stokes & Morley, 1981) that the effectiveness of SCG in the treatment of asthma could be unrelated to mast cell stabilization and be dependent upon other properties such as effects on irritant receptors. This would provide a further explanation for its lack of inhibitory effect on the allergen induced skin weal.…”
Section: Discussionmentioning
confidence: 99%